123
4 Page 4 of 20
56...20
Major depressive disorder (MDD) remains a top cause of disability worldwide and in the United States. In the U.S., roughly one in six people will have at least one episode of MDD over their lives. When combined with chronic medical conditions, as it freq
Member: $0.00
Non-Member: $0.00
1.50 AAPA Category 1 CME credit
What is 2021 Executive Leadership Tuesdays? 2021 Executive Leadership Tuesdays is a series of 5 webinars that will provide timely information to help you stay up-to-speed on the ever-changing healthcare environment and improve your healthcare leader
Member: $199.00
Non-Member: $299.00
6.25 AAPA Category 1 CME credit
Heart failure (HF) exacts a significant toll on affected individuals, placing them at risk of morbidity, diminished functional abilities, lesser quality of life, and mortality. More than 5.8 million Americans have HF, with over 550,000 diagnosed each yea
Member: $0.00
Non-Member: $0.00
1.00 AAPA Category 1 CME credit
Heart failure (HF) exacts a significant toll on affected individuals, placing them at risk of morbidity, diminished functional abilities, lesser quality of life, and mortality. More than 5.8 million Americans have HF, with over 550,000 diagnosed each yea
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 Self-Assessment CME credit
Heart failure (HF) exacts a significant toll on affected individuals, placing them at risk of morbidity, diminished functional abilities, lesser quality of life, and mortality. More than 5.8 million Americans have HF, with over 550,000 diagnosed each yea
Member: $0.00
Non-Member: $0.00
1.75 AAPA Category 1 CME credit
A Review of Inherited Cancer Susceptibility Syndromes | An Overview of Cleft Lip and Palate
Member: $0.00
Non-Member: $25.00
1.00 AAPA Category 1 CME credit
In this not-to-be-missed session, independent agency WPP/Landor* and AAPA provide their reports in response to the 2018 AAPA House of Delegates Resolution requesting a PA Title Change Investigation. Learn about WPP/Landor’s research with various stakeh
Member: $0.00
Non-Member: $25.00
2.00 AAPA Category 1 CME credit
Hypoglycemia remains the rate-limiting factor in the achievement of glycemic goals in patients with type 2 diabetes mellitus (T2DM) treated with pharmacotherapy. Unfortunately, hypoglycemia is common among patients with type 1 and type 2 diabetes mellitu
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 Self-Assessment CME credit
Hypoglycemia remains the rate-limiting factor in the achievement of glycemic goals in patients with type 2 diabetes mellitus (T2DM) treated with pharmacotherapy. Unfortunately, hypoglycemia is common among patients with type 1 and type 2 diabetes mellitu
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 Self-Assessment CME credit
Hypoglycemia remains the rate-limiting factor in the achievement of glycemic goals in patients with type 2 diabetes mellitus (T2DM) treated with pharmacotherapy. Unfortunately, hypoglycemia is common among patients with type 1 and type 2 diabetes mellitu
Member: $0.00
Non-Member: $0.00
1.50 AAPA Category 1 CME credit
123
4 Page 4 of 20
56...20